UHRF2 and intrahepatic cholangiocarcinoma: Increased expression of UHRF2 in esophageal squamous cell carcinoma [12, 14] is negatively associated with cancer progression, whereas the reverse was true in non-small cell lung cancer [11], colorectal cancer [29], gastric cancer, and intrahepatic cholangiocarcinoma.